Bain Capital Life Sciences Fund, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Pharvaris N.V. Ordinary Shares, Euro 0.12 par value per share (PHVS)

Filing Manager
Bain Capital Life Sciences Fund, L.P.
Reporting Manager
Bain Capital Life Sciences Fund, L.P.
Security
Pharvaris N.V. Ordinary Shares, Euro 0.12 par value per share
Symbol
PHVS
Shares outstanding
65,632,680 shares
Disclosed Ownership
1,640,817 shares
Ownership
2.5%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:30:03 UTC
Date of event
31 Dec 2025
Previous filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bain Capital Life Sciences Fund, L.P. 2.5% 1,640,817 0 1,640,817 /s/ Ricky Sun Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC
BCIP Life Sciences Associates, LP 0.3% 167,950 0 167,950 /s/ Ricky Sun Ricky Sun, Authorized Signatory of Boylston Coinvestors, LLC
Bain Capital Life Sciences Opportunities III, LP 1.5% 993,314 0 993,314 /s/ Ricky Sun Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC